Stay updated on IMM60 and Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.

Latest updates to the IMM60 and Pembrolizumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedVersion 10 adds Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, IPDSharing, and Document Section to the record, and includes a QC note 'Quality Control Review Has Not Concluded' with a Returned entry dated 2026-03-24.SummaryDifference1%

- Check19 days agoChange DetectedRevision: v3.5.0 was added and revision: v3.4.3 was removed from the history.SummaryDifference0.1%

- Check26 days agoChange DetectedAdded a 'Results Submitted' entry in the Record History and updated the version to v3.4.3. The previous 'No Results Posted' entry was removed.SummaryDifference0.2%

- Check54 days agoChange DetectedA new revision tag 'Revision: v3.4.2' is added to the history, and the page removes a funding-notice about government operations as well as the earlier 'Revision: v3.4.1' entry. These are minor version-tracking updates and do not alter study data or core page content.SummaryDifference0.8%

- Check61 days agoChange DetectedNotice about government funding and operating status added; revision history updated to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check68 days agoChange DetectedUI changes to the study record history include a Show glossary option, visual color coding for changes, and new revision labeling (Revision: v3.4.0) replacing prior labeling. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to IMM60 and Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM60 and Pembrolizumab Clinical Trial page.